Hospira Drug Shortage Suit Must Be Revived, 11th Circ. Told
A putative class of individuals affected by Hospira Inc.'s decision to stop producing an injectable vitamin supplement on Thursday urged the Eleventh Circuit to revive their suit, alleging other companies may...To view the full article, register now.
Already a subscriber? Click here to view full article